These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 27532934)

  • 1. JAMA PATIENT PAGE. Screening for Lipid Disorders in Children and Adolescents.
    Livingston EH
    JAMA; 2016 Aug; 316(6):678. PubMed ID: 27532934
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipid Screening in Children and Adolescents.
    Urbina EM; de Ferranti SD
    JAMA; 2016 Aug; 316(6):589-91. PubMed ID: 27532913
    [No Abstract]   [Full Text] [Related]  

  • 3. Lipid Screening in Childhood and Adolescence for Detection of Multifactorial Dyslipidemia: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Lozano P; Henrikson NB; Morrison CC; Dunn J; Nguyen M; Blasi PR; Whitlock EP
    JAMA; 2016 Aug; 316(6):634-44. PubMed ID: 27532918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for Lipid Disorders in Children and Adolescents: US Preventive Services Task Force Recommendation Statement.
    ; Barry MJ; Nicholson WK; Silverstein M; Chelmow D; Coker TR; Davis EM; Donahue KE; Jaén CR; Li L; Ogedegbe G; Rao G; Ruiz JM; Stevermer J; Tsevat J; Underwood SM
    JAMA; 2023 Jul; 330(3):253-260. PubMed ID: 37462699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for Lipid Disorders in Children and Adolescents: US Preventive Services Task Force Recommendation Statement.
    ; Bibbins-Domingo K; Grossman DC; Curry SJ; Davidson KW; Epling JW; García FA; Gillman MW; Kemper AR; Krist AH; Kurth AE; Landefeld CS; LeFevre M; Mangione CM; Owens DK; Phillips WR; Phipps MG; Pignone MP; Siu AL
    JAMA; 2016 Aug; 316(6):625-33. PubMed ID: 27532917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid screening and treatment recommendations for children and adolescents.
    McBride PE; Kavey RE
    Pediatr Ann; 2012 Jul; 41(7):1-10. PubMed ID: 22765031
    [No Abstract]   [Full Text] [Related]  

  • 7. A review of guidelines for dyslipidemia in children and adolescents.
    Peterson AL; McBride PE
    WMJ; 2012 Dec; 111(6):274-81; quiz 282. PubMed ID: 23362704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anatomy of a US Preventive Services Task Force Recommendation: lipid screening for children and adolescents.
    Grossman DC; Moyer VA; Melnyk BM; Chou R; DeWitt TG;
    Arch Pediatr Adolesc Med; 2011 Mar; 165(3):205-10. PubMed ID: 21383269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Universal lipid screening in children and adolescents: a baby step toward primordial prevention?
    Saenger AK
    Clin Chem; 2012 Aug; 58(8):1179-81. PubMed ID: 22510399
    [No Abstract]   [Full Text] [Related]  

  • 10. Reframing the US Preventive Services Task Force recommendations on screening for glaucoma.
    Parrish RK
    Am J Ophthalmol; 2014 Nov; 158(5):860-2. PubMed ID: 25437830
    [No Abstract]   [Full Text] [Related]  

  • 11. Preventive Statin Use Recommended by US Task Force.
    Kuehn BM
    Circulation; 2017 Feb; 135(8):806-807. PubMed ID: 28223326
    [No Abstract]   [Full Text] [Related]  

  • 12. JAMA PATIENT PAGE. Screening for Syphilis.
    Jin J
    JAMA; 2016 Jun; 315(21):2367. PubMed ID: 27272600
    [No Abstract]   [Full Text] [Related]  

  • 13. Screening for Lipid Disorders in Children and Adolescents.
    Jin J
    JAMA; 2023 Jul; 330(3):292. PubMed ID: 37462703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of inherited atherogenic dyslipidemias in children.
    Guardamagna O; Cagliero P; Abello F
    Ther Apher Dial; 2013 Apr; 17(2):150-61. PubMed ID: 23551671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vision screening for children 1 to 5 years of age: US Preventive Services Task Force Recommendation statement.
    US Preventive Services Task Force
    Pediatrics; 2011 Feb; 127(2):340-6. PubMed ID: 21282267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening adolescents for lipid disorders: what is the best approach?
    Jenssen BP; Jacobson MS
    Adolesc Med State Art Rev; 2008 Dec; 19(3):507-20, x. PubMed ID: 19227389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The editor's roundtable: expanded versus standard lipid panels in assessing and managing cardiovascular risk.
    Sulkes D; Brown BG; Krauss RM; Segrest JP; Sniderman AD; Roberts WC
    Am J Cardiol; 2008 Mar; 101(6):828-42. PubMed ID: 18328849
    [No Abstract]   [Full Text] [Related]  

  • 18. Newborn hearing screening: recommendations and rationale.
    Am Fam Physician; 2001 Dec; 64(12):1995-9. PubMed ID: 11775766
    [No Abstract]   [Full Text] [Related]  

  • 19. Screening for primary hypertension in children and adolescents: U.S. Preventive Services Task Force recommendation statement.
    Moyer VA;
    Pediatrics; 2013 Nov; 132(5):907-14. PubMed ID: 24101758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening all children for lipid disorders.
    Shulman ST
    Pediatr Ann; 2012 Jul; 41(7):260-1. PubMed ID: 22765033
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.